AbbVie (NYSE: ABBV) announced the global Phase 3 VERONA trial evaluating venetoclax in combination with azacitidine in the treatment of newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS) ...

The enzyme arginase-II has an important role in cardiac aging, and blocking it could help hearts stay young longer.

The following is a summary of “ER-α36 prevents high glucose-induced cellular senescence and apoptosis in renal tubular cell,” ...

Fos, are integral to the brain's response to stimuli. Initially identified as a proto-oncogene, c-Fos is essential for neural ...

Some bat species can live cancer-free for up to 25 years, which is equivalent to 180 human years. How do they do it?

Programmed cell death serves as a critical defense mechanism during viral infection. The kinases RIPK1 and RIPK3, central ...

A study to look at why long-lived bats do not get cancer has broken new ground about the biological defenses that resist the ...

Researchers from Toronto Metropolitan University and St. Michael’s Hospital have developed a method of delivering ...

Researchers at MD Anderson discussed the five possible approaches to treating graft-versus-host disease in a review article ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced ...